# Capturing Readmission Internationally to Prevent Readmission by Safer@Home Group

> **NCT02621723** · — · UNKNOWN · sponsor: **Amsterdam UMC, location VUmc** · enrollment: 1000 (estimated)

## Conditions studied

- Hospital Readmission

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02621723
- **Lead sponsor:** Amsterdam UMC, location VUmc
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2017-01
- **Final completion:** 2018-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2015-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02621723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02621723, "Capturing Readmission Internationally to Prevent Readmission by Safer@Home Group". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02621723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*